Pharmacy Usual Items - Eastern Asia

  • Eastern Asia
  • Revenue in the Pharmacy Usual Items market is projected to reach US$66.25bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.72%, resulting in a market volume of US$82.76bn by 2028.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$40.53 are generated in 2024.

Key regions: Canada, United States, France, South Korea, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Eastern Asia is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend. Customer preferences in Eastern Asia play a crucial role in the development of the Pharmacy Usual Items market. Consumers in this region have a strong emphasis on health and wellness, leading to increased demand for pharmaceutical products. With a growing middle class and increased disposable income, consumers are willing to spend more on healthcare products, including over-the-counter medications and personal care items. Additionally, the aging population in Eastern Asia has created a higher demand for medications and healthcare products, further driving market growth. Trends in the market also contribute to the development of the Pharmacy Usual Items market in Eastern Asia. There is a growing trend towards self-medication and self-care in this region. Consumers are increasingly seeking out over-the-counter medications and personal care items to manage minor health issues and maintain their well-being. This trend is supported by the availability of a wide range of pharmacy usual items in Eastern Asia, making it convenient for consumers to access the products they need. E-commerce platforms and online pharmacies have also gained popularity, providing consumers with easy and convenient access to pharmacy usual items. Local special circumstances also impact the Pharmacy Usual Items market in Eastern Asia. Government policies and regulations play a significant role in shaping the market landscape. In some countries, the government has implemented measures to promote the use of generic medicines, which has led to increased competition and lower prices. Additionally, the presence of local manufacturers and brands in Eastern Asia has created a diverse and competitive market, offering consumers a wide range of options. Underlying macroeconomic factors contribute to the growth of the Pharmacy Usual Items market in Eastern Asia. The region has experienced steady economic growth, leading to increased consumer spending power. Rising healthcare awareness, coupled with increasing urbanization and lifestyle changes, has resulted in higher demand for pharmacy usual items. Furthermore, advancements in technology and infrastructure have made it easier for consumers to access healthcare products, contributing to market growth. In conclusion, the Pharmacy Usual Items market in Eastern Asia is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The emphasis on health and wellness, the trend towards self-medication, government policies, and economic growth all contribute to the positive growth and development of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)